Affluent Medical SA
Affluent Medical SA AFME.PA Peers
See (AFME.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AFME.PA | $1.33 | +2.31% | 52.14M | -3.50 | -$0.38 | N/A |
| PHIA.AS | $21.97 | +0.50% | 20.32B | 84.50 | $0.26 | N/A |
| IBAB.BR | $11.56 | +1.58% | 338.66M | 42.81 | $0.27 | +1.03% |
| GBT.PA | $21.20 | -0.24% | 267.19M | 19.81 | $1.07 | +2.36% |
| EAPI.PA | $2.76 | +2.22% | 262.83M | -2.00 | -$1.38 | N/A |
| ALERS.PA | $25.30 | N/A | 253.14M | 64.87 | $0.39 | N/A |
| ALCOR.PA | $35.10 | +0.29% | 154.53M | -234.00 | -$0.15 | N/A |
| SEQUA.BR | $1.08 | -0.74% | 57.70M | -1.19 | -$0.91 | N/A |
| ALCAR.PA | $0.80 | +1.41% | 47.00M | -0.69 | -$1.15 | N/A |
| ALMDT.PA | $2.27 | +1.12% | 43.21M | -1.65 | -$1.37 | N/A |
Stock Comparison
AFME.PA vs PHIA.AS Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, PHIA.AS has a market cap of 20.32B. Regarding current trading prices, AFME.PA is priced at $1.33, while PHIA.AS trades at $21.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas PHIA.AS's P/E ratio is 84.50. In terms of profitability, AFME.PA's ROE is -0.51%, compared to PHIA.AS's ROE of -0.06%. Regarding short-term risk, AFME.PA is less volatile compared to PHIA.AS. This indicates potentially lower risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs IBAB.BR Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, IBAB.BR has a market cap of 338.66M. Regarding current trading prices, AFME.PA is priced at $1.33, while IBAB.BR trades at $11.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas IBAB.BR's P/E ratio is 42.81. In terms of profitability, AFME.PA's ROE is -0.51%, compared to IBAB.BR's ROE of +0.09%. Regarding short-term risk, AFME.PA is more volatile compared to IBAB.BR. This indicates potentially higher risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs GBT.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, GBT.PA has a market cap of 267.19M. Regarding current trading prices, AFME.PA is priced at $1.33, while GBT.PA trades at $21.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas GBT.PA's P/E ratio is 19.81. In terms of profitability, AFME.PA's ROE is -0.51%, compared to GBT.PA's ROE of +0.04%. Regarding short-term risk, AFME.PA is more volatile compared to GBT.PA. This indicates potentially higher risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs EAPI.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, EAPI.PA has a market cap of 262.83M. Regarding current trading prices, AFME.PA is priced at $1.33, while EAPI.PA trades at $2.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas EAPI.PA's P/E ratio is -2.00. In terms of profitability, AFME.PA's ROE is -0.51%, compared to EAPI.PA's ROE of -0.14%. Regarding short-term risk, AFME.PA is less volatile compared to EAPI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs ALERS.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, ALERS.PA has a market cap of 253.14M. Regarding current trading prices, AFME.PA is priced at $1.33, while ALERS.PA trades at $25.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas ALERS.PA's P/E ratio is 64.87. In terms of profitability, AFME.PA's ROE is -0.51%, compared to ALERS.PA's ROE of +0.02%. Regarding short-term risk, AFME.PA is more volatile compared to ALERS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs ALCOR.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, ALCOR.PA has a market cap of 154.53M. Regarding current trading prices, AFME.PA is priced at $1.33, while ALCOR.PA trades at $35.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas ALCOR.PA's P/E ratio is -234.00. In terms of profitability, AFME.PA's ROE is -0.51%, compared to ALCOR.PA's ROE of -0.23%. Regarding short-term risk, AFME.PA is more volatile compared to ALCOR.PA. This indicates potentially higher risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs SEQUA.BR Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, SEQUA.BR has a market cap of 57.70M. Regarding current trading prices, AFME.PA is priced at $1.33, while SEQUA.BR trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas SEQUA.BR's P/E ratio is -1.19. In terms of profitability, AFME.PA's ROE is -0.51%, compared to SEQUA.BR's ROE of +2.05%. Regarding short-term risk, AFME.PA is less volatile compared to SEQUA.BR. This indicates potentially lower risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs ALCAR.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, ALCAR.PA has a market cap of 47.00M. Regarding current trading prices, AFME.PA is priced at $1.33, while ALCAR.PA trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas ALCAR.PA's P/E ratio is -0.69. In terms of profitability, AFME.PA's ROE is -0.51%, compared to ALCAR.PA's ROE of +1.40%. Regarding short-term risk, AFME.PA is more volatile compared to ALCAR.PA. This indicates potentially higher risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs ALMDT.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, ALMDT.PA has a market cap of 43.21M. Regarding current trading prices, AFME.PA is priced at $1.33, while ALMDT.PA trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas ALMDT.PA's P/E ratio is -1.65. In terms of profitability, AFME.PA's ROE is -0.51%, compared to ALMDT.PA's ROE of +0.90%. Regarding short-term risk, AFME.PA is less volatile compared to ALMDT.PA. This indicates potentially lower risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs ALNOV.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, ALNOV.PA has a market cap of 32.98M. Regarding current trading prices, AFME.PA is priced at $1.33, while ALNOV.PA trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas ALNOV.PA's P/E ratio is -0.77. In terms of profitability, AFME.PA's ROE is -0.51%, compared to ALNOV.PA's ROE of -0.23%. Regarding short-term risk, AFME.PA is less volatile compared to ALNOV.PA. This indicates potentially lower risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs MKEA.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, MKEA.PA has a market cap of 30.17M. Regarding current trading prices, AFME.PA is priced at $1.33, while MKEA.PA trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas MKEA.PA's P/E ratio is -2.49. In terms of profitability, AFME.PA's ROE is -0.51%, compared to MKEA.PA's ROE of +0.74%. Regarding short-term risk, AFME.PA is more volatile compared to MKEA.PA. This indicates potentially higher risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs ALIKO.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, ALIKO.PA has a market cap of 22.07M. Regarding current trading prices, AFME.PA is priced at $1.33, while ALIKO.PA trades at $1.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas ALIKO.PA's P/E ratio is -6.08. In terms of profitability, AFME.PA's ROE is -0.51%, compared to ALIKO.PA's ROE of -0.17%. Regarding short-term risk, AFME.PA is more volatile compared to ALIKO.PA. This indicates potentially higher risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs ALDMS.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, ALDMS.PA has a market cap of 19.21M. Regarding current trading prices, AFME.PA is priced at $1.33, while ALDMS.PA trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas ALDMS.PA's P/E ratio is -8.17. In terms of profitability, AFME.PA's ROE is -0.51%, compared to ALDMS.PA's ROE of -0.25%. Regarding short-term risk, AFME.PA is more volatile compared to ALDMS.PA. This indicates potentially higher risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs ALTER.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, ALTER.PA has a market cap of 17.29M. Regarding current trading prices, AFME.PA is priced at $1.33, while ALTER.PA trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas ALTER.PA's P/E ratio is 42.00. In terms of profitability, AFME.PA's ROE is -0.51%, compared to ALTER.PA's ROE of -0.06%. Regarding short-term risk, AFME.PA is less volatile compared to ALTER.PA. This indicates potentially lower risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs ALTHE.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, ALTHE.PA has a market cap of 13.56M. Regarding current trading prices, AFME.PA is priced at $1.33, while ALTHE.PA trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas ALTHE.PA's P/E ratio is -2.25. In terms of profitability, AFME.PA's ROE is -0.51%, compared to ALTHE.PA's ROE of -1.29%. Regarding short-term risk, AFME.PA is less volatile compared to ALTHE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs ALIMP.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, ALIMP.PA has a market cap of 12.66M. Regarding current trading prices, AFME.PA is priced at $1.33, while ALIMP.PA trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas ALIMP.PA's P/E ratio is -2.53. In terms of profitability, AFME.PA's ROE is -0.51%, compared to ALIMP.PA's ROE of -2.06%. Regarding short-term risk, AFME.PA is less volatile compared to ALIMP.PA. This indicates potentially lower risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs ALEMG.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, ALEMG.PA has a market cap of 11.22M. Regarding current trading prices, AFME.PA is priced at $1.33, while ALEMG.PA trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas ALEMG.PA's P/E ratio is 26.31. In terms of profitability, AFME.PA's ROE is -0.51%, compared to ALEMG.PA's ROE of +0.81%. Regarding short-term risk, AFME.PA is more volatile compared to ALEMG.PA. This indicates potentially higher risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs ALBLU.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, ALBLU.PA has a market cap of 7.61M. Regarding current trading prices, AFME.PA is priced at $1.33, while ALBLU.PA trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas ALBLU.PA's P/E ratio is -6.20. In terms of profitability, AFME.PA's ROE is -0.51%, compared to ALBLU.PA's ROE of -0.61%. Regarding short-term risk, AFME.PA is less volatile compared to ALBLU.PA. This indicates potentially lower risk in terms of short-term price fluctuations for AFME.PA.
AFME.PA vs ALSGD.PA Comparison
AFME.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AFME.PA stands at 52.14M. In comparison, ALSGD.PA has a market cap of 6.53M. Regarding current trading prices, AFME.PA is priced at $1.33, while ALSGD.PA trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AFME.PA currently has a P/E ratio of -3.50, whereas ALSGD.PA's P/E ratio is -1.17. In terms of profitability, AFME.PA's ROE is -0.51%, compared to ALSGD.PA's ROE of -0.59%. Regarding short-term risk, AFME.PA is less volatile compared to ALSGD.PA. This indicates potentially lower risk in terms of short-term price fluctuations for AFME.PA.